威灵仙浓煎雾化吸入联合口腔功能训练在脑卒中吞咽功能障碍患者中的应用研究  

Application Research of Weilingxian Concentrated Decoction Nebulized Inhalation Combined with Oral Function Training on Stroke Patients with Swallowing Disorders

作　　者：毛芳[1] 陈迪 宋杰[1] 黄金凤 王楠楠[1] MAO Fang;CHEN Di;SONG Jie;HUANG Jinfeng;WANG Nannan(Department of Neurology Second Waxd,Second Affiliated Hospital of Qiqihar Medical College,Qiqihar 161000,China;Department of Neurology Sixth Ward,Second Affiliated Hospital of Qiqihar Medical College,Six Disease Areas,Qiqihar 161000,China)

机构地区：[1]齐齐哈尔医学院附属第二医院神经内科二病区,黑龙江齐齐哈尔161000 [2]齐齐哈尔医学院附属第二医院神经内科六病区,黑龙江齐齐哈尔161000

出　　处：《反射疗法与康复医学》2024年第11期45-48,共4页Reflexology And Rehabilitation Medicine

摘　　要：目的探讨威灵仙浓煎雾化吸入联合口腔功能训练治疗脑卒中吞咽功能障碍患者的临床效果。方法选取2022年12月—2023年11月齐齐哈尔医学院附属第二医院收治的84例脑卒中吞咽功能障碍患者为研究对象,按随机数字表法将其分为对照组和观察组,各42例。对照组采用口腔功能训练干预,观察组采用威灵仙浓煎雾化吸入干预,两组均持续干预2周。比较两组临床疗效、吞咽及摄食功能、营养状况、生活质量。结果观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。干预后,观察组吞咽功能评定量表评分(20.42±2.35)分低于对照组的(25.73±2.73)分,功能性经口摄食量表评分(5.49±0.87)分高于对照组的(4.75±0.69)分,组间差异有统计学意义(P<0.05);观察组白蛋白水平(40.15±4.32)g/L、总蛋白水平(67.65±5.32)g/L均高于对照组的(35.68±3.87)g/L、(60.54±5.29)g/L,组间差异有统计学意义(P<0.05);观察组心理、生理、社会关系、环境领域维度评分分别为(86.38±5.39)分、(85.24±5.15)分、(87.47±4.32)分、(88.17±4.75)分,均高于对照组的(82.09±5.31)分、(79.17±5.12)分、(80.45±5.13)分、(82.12±5.17)分,组间差异有统计学意义(P<0.05)。结论威灵仙浓煎雾化吸入联合口腔功能训练可提高脑卒中吞咽功能障碍患者疗效,加快吞咽功能恢复,以纠正机体营养状态,更好改善生活质量。Objective To explore the clinical effect of Weilingxian concentrated decoction nebulized inhalation combined with oral function training in the treatment of stroke patients with swallowing disorders.Methods A total of 84 stroke patients with swallowing disorders treated at the Second Affiliated Hospital of Qiqihar Medical College from December 2022 to November 2023 were selected and randomly divided into a control group and an observation group,with 42 cases in each group.The control group received oral function training intervention,while the observation group received nebulized inhalation intervention of Weilingxian concentrated decoction,both groups antinued to intervene for 2 weeks.Compare the clinical efficacy,swallowing and feeding function,nutritional status,and quality of life between two groups.Results The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After intervention,the Standardized Swallowing Assessment score of the observation group(20.42±2.35)points was lower than(25.73±2.73)points of the control group,and the Functional Oral Intake Scale score(5.49±0.87)points was higher than(4.75±0.69)points of the control group,and the differences between the groups were statistically significant(P<0.05);the levels of ALB(40.15±4.32)g/L and TP(67.65±5.32)g/L in the observation group were higher than(35.68±3.87)g/L and(60.54±5.29)g/L in the control group,with statistically significant differences between the groups(P<0.05);the psychological,physiological,social relations,and environmental field dimensions in the observation group were(86.38±5.39)points,(85.24±5.15)points,(87.47±4.32)points,and(88.17±4.75)points,respectively,which were higher than(82.09±5.31)points,(79.17±5.12)points,(80.45±5.13)points,and(82.12±5.17)points in the control group,with statistically significant differences between the groups(P<0.05).Conclusion The combination of Weilingxian concentrated decoction nebulized inhalation an

关 键 词：脑卒中吞咽功能障碍 威灵仙浓煎雾化吸入 口腔功能训练 吞咽功能 

分 类 号：R743[医药卫生—神经病学与精神病学]